Paper Details

  1. Home
  2. Paper Details

Ubrogepant to Treat Acute Migraine in Adults.

Author: BourgMargaret M, CaseyC Austin, ColonMarc A, EdinoffAmber N, GregoireCourtney M, KayeAdam M, KayeAlan D, KayeJessica S, KayeRachel J, TirumalaSridhar R, UritsIvan, ViswanathOmar, ZaheriAlexa R

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Ubrogepant is a new medication for the acute treatment of migraines with or without aura in adults. It has good tolerability and an overall favorable safety profile, with the most common side effects being oropharyngeal pain, nasopharyngitis, and headache. In most studies, participants taking Ubrogepant were free from pain within 2 hours compared to placebo. However, patients taking Ubrogepant should avoid taking it when pregnant or with end-stage renal disease.
Paper Details　
Original Abstract of the Article :
Migraine is a neurobiological headache disorder that affects around 16% of adults in the United States. Medical treatment of mild to moderate migraines include non-prescription non-steroidal anti-inflammatory drugs, acetaminophen, or aspirin and caffeine-containing combination analgesics. Additional...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931025/

データ提供：米国国立医学図書館（NLM）

Ubrogepant to Treat Acute Migraine in Adults

Migraine is a debilitating condition affecting millions of adults worldwide. This study explores the effectiveness of ubrogepant, a novel CGRP receptor antagonist, in treating acute migraine. The researchers compared ubrogepant to a placebo in a clinical trial setting. Their findings suggest that ubrogepant offers a safe and effective treatment option for adults experiencing acute migraine episodes.

Ubrogepant: A Promising Treatment Option for Migraine

This research emphasizes the potential of ubrogepant for treating migraine with or without aura in adults. The study's findings suggest that ubrogepant offers a safe and effective option for those seeking relief from acute migraine episodes. This is a significant development, as it provides another tool for effectively managing this debilitating condition.

Navigating Migraine with Ubrogepant

The study's findings are a beacon of hope for those who experience the painful effects of migraine. Ubrogepant's effectiveness and favorable safety profile make it a promising treatment option for acute migraine episodes. It is essential to consult a healthcare professional to discuss individual needs and potential benefits. The desert of migraine can feel vast and endless, but this research offers a potential oasis of relief for many sufferers.

Dr.Camel's Conclusion

The study's findings are encouraging for individuals struggling with migraine. Ubrogepant holds promise as a safe and effective treatment for acute migraine episodes, potentially offering relief to those experiencing the debilitating effects of this condition. It's important to continue exploring the use of ubrogepant in managing migraine, ensuring optimal treatment strategies for individuals with this condition.
Date :
  1. Date Completed n.d.
  2. Date Revised 2023-11-11
Further Info :

Pubmed ID

33525313

DOI: Digital Object Identifier

PMC7931025

Related Literature

Article Analysis
・Side Effects of ubrogepant
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.